David Mims

Directeur Général chez PROGENICS PHARMACEUTICALS, INC.

Profil

David W.
Mims currently works at Progenics Pharmaceuticals, Inc., as Chief Executive Officer, SouthPoint Bank, as Director from 2015, Guideway Care, Inc., as Director from 2017, The American Institute of Certified Public Accountants, as Member, and Alabama Society of Certified Public Accountants, as Member.
Mr. Mims also formerly worked at The University of Alabama, as Director, SouthPoint Bancshares, Inc., as Director, Ernst & Young LLP, as Senior Accountant, Aptalis Pharma Canada ULC, as Chief Operating Officer & Executive Vice President, Aptalis Pharma LLC, as President-US Specialty Pharmaceuticals in 2011, Aptalis Pharma US, Inc., as Chief Operating & Financial Officer from 1991 to 1998, and Cebert Pharmaceuticals, Inc., as Chief Operating Officer & Executive Vice President.
Mr. Mims received his undergraduate degree from Auburn University.

Postes actifs de David Mims

Sociétés	Poste	Début
PROGENICS PHARMACEUTICALS, INC.	Directeur Général	-
The American Institute of Certified Public Accountants	Corporate Officer/Principal	-
Alabama Society of Certified Public Accountants	Corporate Officer/Principal	-
Guideway Care, Inc.	Directeur/Membre du Conseil	01/05/2017
SouthPoint Bank	Directeur/Membre du Conseil	01/08/2015

Anciens postes connus de David Mims

Sociétés	Poste	Fin
The University of Alabama	Directeur/Membre du Conseil	17/12/2010
Cebert Pharmaceuticals, Inc.	Directeur des opérations	-
Aptalis Pharma US, Inc.	Directeur Financier/CFO	01/01/1998
SOUTHPOINT BANCSHARES, INC.	Directeur/Membre du Conseil	-
░░░░░░░ ░░░░░░ ░░░░░░ ░░░	░░░░░░░░░ ░░░ ░░░░░░░░░░░	-